D H Pamphilon Selected Research

Alemtuzumab (Campath)

1/2004	Influence of cytomegalovirus (CMV) sero-positivity on CMV infection, lymphocyte recovery and non-CMV infections following T-cell-depleted allogeneic stem cell transplantation: a comparison between two T-cell depletion regimens.
1/2000	T cell-depleted unrelated donor bone marrow transplantation for acute myeloid leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

D H Pamphilon Research Topics

Disease

2	Infections 01/2004 - 12/2000
1	Osteopetrosis 02/2005
1	Neoplasms (Cancer) 07/2003
1	Mycoses (Diseases, Fungus) 04/2001
1	Thrombotic Thrombocytopenic Purpura 04/2001
1	Disease Progression 12/2000
1	Adenoviridae Infections (Adenovirus Infections) 12/2000
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2000
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2000
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2000
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2000

Drug/Important Bio-Agent (IBA)

2	Alemtuzumab (Campath)FDA Link 01/2004 - 01/2000
2	3,4,3',4'-tetrachloroazobenzeneIBA 01/2004 - 07/2003
1	thiamine triphosphorate (TTP)IBA 04/2001
1	antineoplaston A10 (A 10)IBA 12/2000
1	Cidofovir (Vistide)FDA Link 12/2000
1	Antiviral Agents (Antivirals)IBA 12/2000
1	Ribavirin (Virazole)FDA LinkGeneric 12/2000

Therapy/Procedure

3	Stem Cell Transplantation 02/2005 - 04/2001
3	Bone Marrow Transplantation (Transplantation, Bone Marrow) 04/2001 - 01/2000
2	Transplantation 01/2000 - 01/2000
1	Plasmapheresis 04/2001
1	Immunomodulation 12/2000
1	Remission Induction 01/2000